Document resource
Interstitial lung disease (ILD) is a common manifestation of systemic sclerosis (SSc) affecting approximately 50% of patients at diagnosis when assessed by high-resolution CT (HRCT).1 ILD is the leading cause of SSc-related mortality and is associated with a threefold increased risk of death in SSc.2 The presence of ILD at SSc diagnosis confers prognostic information.1 Early identification of SSc-ILD may influence the timing of treatment initiation, thus improving outcomes.